203 related articles for article (PubMed ID: 11259363)
1. A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2.
Hagedorn M; Zilberberg L; Lozano RM; Cuevas P; Canron X; Redondo-Horcajo M; Gimenez-Gallego G; Bikfalvi A
FASEB J; 2001 Mar; 15(3):550-2. PubMed ID: 11259363
[TBL] [Abstract][Full Text] [Related]
2. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
[TBL] [Abstract][Full Text] [Related]
3. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis.
Jia H; Lohr M; Jezequel S; Davis D; Shaikh S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 May; 283(2):469-79. PubMed ID: 11327725
[TBL] [Abstract][Full Text] [Related]
4. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
5. Direct FGF receptor 1 activation through an anti-idiotypic strategy mimicks the biological activity of FGF-2 and inhibits the progression of the bladder carcinoma derived from NBT-II cells.
Malavaud B; Pedron S; Sordello S; Mazerolles C; Billottet C; Thiery JP; Jouanneau J; Plouët J
Oncogene; 2004 Sep; 23(40):6769-78. PubMed ID: 15273729
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.
Mohammadi M; Froum S; Hamby JM; Schroeder MC; Panek RL; Lu GH; Eliseenkova AV; Green D; Schlessinger J; Hubbard SR
EMBO J; 1998 Oct; 17(20):5896-904. PubMed ID: 9774334
[TBL] [Abstract][Full Text] [Related]
7. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
8. Pigment epithelium-derived factor inhibits fibroblast-growth-factor-2-induced capillary morphogenesis of endothelial cells through Fyn.
Kanda S; Mochizuki Y; Nakamura T; Miyata Y; Matsuyama T; Kanetake H
J Cell Sci; 2005 Mar; 118(Pt 5):961-70. PubMed ID: 15713745
[TBL] [Abstract][Full Text] [Related]
9. Signaling via fibroblast growth factor receptor-1 is dependent on extracellular matrix in capillary endothelial cell differentiation.
Kanda S; Tomasini-Johansson B; Klint P; Dixelius J; Rubin K; Claesson-Welsh L
Exp Cell Res; 1999 Apr; 248(1):203-13. PubMed ID: 10094827
[TBL] [Abstract][Full Text] [Related]
10. The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo.
Vandercappellen J; Liekens S; Bronckaers A; Noppen S; Ronsse I; Dillen C; Belleri M; Mitola S; Proost P; Presta M; Struyf S; Van Damme J
Mol Cancer Res; 2010 Mar; 8(3):322-34. PubMed ID: 20215425
[TBL] [Abstract][Full Text] [Related]
11. Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound.
Miao HQ; Ornitz DM; Aingorn E; Ben-Sasson SA; Vlodavsky I
J Clin Invest; 1997 Apr; 99(7):1565-75. PubMed ID: 9120000
[TBL] [Abstract][Full Text] [Related]
12. Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization.
Perollet C; Han ZC; Savona C; Caen JP; Bikfalvi A
Blood; 1998 May; 91(9):3289-99. PubMed ID: 9558385
[TBL] [Abstract][Full Text] [Related]
13. The control of angiogenesis and tumor invasion by platelet factor-4 and platelet factor-4-derived molecules.
Bikfalvi A; Gimenez-Gallego G
Semin Thromb Hemost; 2004 Feb; 30(1):137-44. PubMed ID: 15034805
[TBL] [Abstract][Full Text] [Related]
14. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.
Takahashi T; Yamaguchi S; Chida K; Shibuya M
EMBO J; 2001 Jun; 20(11):2768-78. PubMed ID: 11387210
[TBL] [Abstract][Full Text] [Related]
15. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
16. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase.
Panek RL; Lu GH; Dahring TK; Batley BL; Connolly C; Hamby JM; Brown KJ
J Pharmacol Exp Ther; 1998 Jul; 286(1):569-77. PubMed ID: 9655904
[TBL] [Abstract][Full Text] [Related]
17. Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival.
Shan S; Robson ND; Cao Y; Qiao T; Li CY; Kontos CD; Garcia-Blanco M; Dewhirst MW
FASEB J; 2004 Feb; 18(2):326-8. PubMed ID: 14688196
[TBL] [Abstract][Full Text] [Related]
18. Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells.
Presta M; Rusnati M; Urbinati C; Sommer A; Ragnotti G
J Cell Physiol; 1991 Dec; 149(3):512-24. PubMed ID: 1660485
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway.
Finetti F; Donnini S; Giachetti A; Morbidelli L; Ziche M
Circ Res; 2009 Sep; 105(7):657-66. PubMed ID: 19713533
[TBL] [Abstract][Full Text] [Related]
20. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
